Blood sugar pill shows promise
October 18, 2017
Source: medicalnewstoday
587
So concluded a phase II clinical trial that found that the pill was better at glycemic control than a placebo over a 26-week period.
A report on the trial — by lead author Dr. Melanie Davies, of the Diabetes Research Centre at the University of Leicester in the United Kingdom, and colleagues — has been published in JAMA.
The results justify phase III trials to assess the longer-term effects and safety of semaglutide in pill form to help patients with type 2 diabetes to control blood sugar, note the authors.
More than 90 percent of the 30 million people living with diabetes in the United States have type 2 diabetes, which is a condition that develops when the body cannot use insulin properly to help cells turn blood sugar, or glucose, into energy.
Many patients can manage their type 2 diabetes by eating a healthful diet, partaking in exercise, and taking medications to help control blood sugar, or achieve glycemic control.
By Ddu
Copyright©2024 Ddu. All rights reserved.
Read more on
- Things to Know before Buying Newborn Baby Incubators March 31, 2022
- Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients August 26, 2021
- Autoantibody order, timing predict genetically at-risk children most likely to get type 1 diabetes October 30, 2020
- Highly Resistant Food Poisoning Bug Responds to Antibiotics September 6, 2018
- Smartphone Based Diagnosis to Identify Mosquitoes Transmitting Infection September 5, 2018
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
